Quantitative Systems Pharmacology Model for Alzheimer's Disease Indicates Targeting Sphingolipid Dysregulation as Potential Treatment Option
CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1002/psp4.12351
Full Text
Open PDFAbstract
Available in full text
Date
October 8, 2018
Authors
Publisher
Wiley